Toronto Dominion Bank’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,100
Closed -$733K 1468
2019
Q1
$733K Buy
3,100
+2,400
+343% +$756K ﹤0.01% 1046
2018
Q4
$211K Buy
+700
New +$223K ﹤0.01% 1095
2018
Q1
Sell
-21,500
Closed -$6.85M 1305
2017
Q4
$6.85M Buy
+21,500
New +$6.9M 0.02% 438

Other funds holding BIIB

Toronto Dominion Bank's BIIB Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Biogen (BIIB) stake by 12% in Q1 2026, selling an estimated $1.07M and leaving 43,371 shares worth $7.95M. The position accounts for 0.01% of the portfolio, ranked #699.

Toronto Dominion Bank first reported a position in BIIB in Q4 2013 and has held it in 50 quarters since. The position peaked at $66.1M in Q1 2015. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Toronto Dominion Bank held 43,371 shares of Biogen worth $7.95M as of Q1 2026.
  • Toronto Dominion Bank sold 5,802 Biogen shares in Q1 2026, an estimated $1.07M.
  • Biogen made up 0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #699 holding.
  • Toronto Dominion Bank first reported a position in Biogen in Q4 2013 and has held it in 50 quarters since.
  • Toronto Dominion Bank's Biogen position peaked at $66.1M in Q1 2015.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.